XM does not provide services to residents of the United States of America.
I
I

Illumina

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

U.S. STOCKS Merck, Microstrategy, Illumina

U.S. STOCKS ON THE MOVE-Merck, Microstrategy, Illumina Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 The S&P 500 and the tech-heavy Nasdaq edged higher on Tuesday, paring earlier losses as investors assessed Russia's warning to the United States with a new nuclear doctrine, and awaited quarterly results from AI-heavyweight Nvidia.
G
I
I
I
N
K
U
U
U
J
L

Illumina rises after co set for global launch of cancer test next year

BUZZ-Illumina rises after co set for global launch of cancer test next year ** Gene-sequencing equipment maker Illumina's ILMN.O shares rise 1.3% to $132.44 ** ILMN's TruSight Oncology 500 v2, a cancer test that uses genetic profiling of blood for DNA fragments of tumor, is set to launch globally in mid-2025, co says ** The test kits are now available to ship in the U.S.
I

Illumina Announces Expansion Of Trusight Oncology Portfolio

BRIEF-Illumina Announces Expansion Of Trusight Oncology Portfolio Nov 19 (Reuters) - Illumina Inc ILMN.O : ILLUMINA ANNOUNCES EXPANSION OF TRUSIGHT ONCOLOGY PORTFOLIO ILLUMINA INC: TRUSIGHT ONCOLOGY 500 V2 ASSAY IS CURRENTLY UNDER DEVELOPMENT, GLOBAL RELEASE PLANNED FOR MID-2025 Source text: ID:nPnbl8H4Ca Further company coverage: ILMN.O
I

Nasdaq top and bottom performing stocks at about 02:45 p.m. EST

BUZZ - Nasdaq top and bottom performing stocks at about 02:45 p.m. EST Nasdaq 100 .NDX Top Performers Percent Change Super Micro Computer Inc SMCI.OQ +23.9% Moderna Inc MRNA.OQ +5.8% Advanced Micro Devices Inc AMD.OQ +3.6% Tesla Inc TSLA.OQ +3.4% PDD Holdings Inc PDD.OQ +3.4% Bottom Performers Percent Change Illumina Inc ILMN.OQ -3.7% Lululemon Athletica Inc LULU.OQ -3.3% Intuit Inc INTU.OQ -1.5% NVIDIA Corp NVDA.OQ -1.4% PayPal Holdings Inc PYPL.OQ -1.3% The Nasdaq 100 .NDX gained 135.26 points
I
I
L
N
P
T
A
U
P

Nasdaq top and bottom performing stocks at about 12:01 p.m. EST

BUZZ - Nasdaq top and bottom performing stocks at about 12:01 p.m. EST Nasdaq 100 .NDX Top Performers Percent Change Super Micro Computer Inc SMCI.OQ +16.9% Tesla Inc TSLA.OQ +7% Moderna Inc MRNA.OQ +6.0% Diamondback Energy Inc FANG.OQ +3.2% Advanced Micro Devices Inc AMD.OQ +3.2% Bottom Performers Percent Change Illumina Inc ILMN.OQ -2.6% Lululemon Athletica Inc LULU.OQ -2.4% NVIDIA Corp NVDA.OQ -1.4% Biogen Inc BIIB.OQ -1.2% Keurig Dr Pepper Inc KDP.OQ -1.2% The Nasdaq 100 .NDX gained 169.50 p
B
I
L
N
T
A
U
D

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.